🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the efficacy and safety of camrelizumab combined with rituximab, ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-01
Trial ID
NCT05093140
Treatments Being Tested
This open-label, randomized, phase Ib study will assess the safety and effi...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00825149
Treatments Being Tested
The purpose of this study is to evaluate the effect of the combined treatme...
Status
Completed
Location
Local Institution - 54103
Start Date
2011-12-29
Trial ID
NCT01476787
Treatments Being Tested
The study is to investigate the safety, tolerability and efficacy of PI3Kδ ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-03
Trial ID
NCT05238064
Treatments Being Tested
The purpose of phase I of this clinical trial is to learn the recommended d...
Status
Not Yet Recruiting
Location
Huntsman Cancer Institute at University of Utah
Start Date
2026-08
Trial ID
NCT07573436
Treatments Being Tested
This study will treat patients with diffuse large B-cell lymphoma (DLBCL). ...
Status
Recruiting
Location
Peking University Third Hospital
Start Date
2025-08-19
Trial ID
NCT07059650
Treatments Being Tested
This study is a multi-center, open-label, single-arm, non-randomized phase ...
Status
Unknown
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2022-02-01
Trial ID
NCT05200312
This is a prospective, single-arm, multi-center, phase II clinical trial to...
Status
Recruiting
Location
Sun yat-sen university cancer center
Start Date
2024-08-01
Trial ID
NCT06517511
Treatments Being Tested
The purpose of this trial is to measure the safety and effectiveness of epc...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-11-03
Trial ID
NCT04663347
Treatments Being Tested
This study is trying to explore the mechanism of R-CHOP regimen or tucidino...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-30
Trial ID
NCT06652152